Birzeit Pharmaceuticals Company (PEX:BPC)

PEX:BPC Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.34	1.03	3.07	3.11	3	1.14
Short-Term Investments	0.5	0.5	0.5	0.5	-	-
Trading Asset Securities	3.2	3.25	11.93	13.58	13.63	12.67
Cash & Short-Term Investments	5.04	4.78	15.5	17.19	16.63	13.81
Cash Growth	18.85%	-69.17%	-9.81%	3.38%	20.39%	8.82%
Accounts Receivable	60.53	50.11	40.74	34.53	37.47	31.74
Other Receivables	-	2.01	1.35	2.13	-	1.19
Receivables	60.53	52.12	42.08	36.66	37.47	32.93
Inventory	14.76	12.76	11.84	13.13	12.2	11.65
Prepaid Expenses	-	0.19	0.27	0.14	-	0.11
Other Current Assets	0.37	0.05	0.37	0.07	1.92	1.12
Total Current Assets	80.7	69.9	70.06	67.19	68.22	59.62
Property, Plant & Equipment	29.88	30.42	29.49	24.31	22.47	21.13
Long-Term Investments	36.17	36.64	27.15	26.97	25.5	24.07
Long-Term Accounts Receivable	1.43	1.26	0.65	0.06	0.05	0.45
Long-Term Deferred Tax Assets	1.86	1.72	1.21	1.27	1.15	1.1
Other Long-Term Assets	0.27	0.27	0.27	5.35	5.61	5.61
Total Assets	150.3	140.21	128.82	125.15	123	111.98

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	-	5.77	3.7	2.03	-	1.59
Accrued Expenses	-	2.09	2.03	2.18	-	2.31
Current Portion of Long-Term Debt	-	-	-	-	0.42	0.85
Current Income Taxes Payable	0.85	0.56	-	-	-	-
Other Current Liabilities	13.86	4.42	7.11	3.97	7.15	2.42
Total Current Liabilities	15.59	12.84	12.85	8.18	7.57	7.18
Long-Term Debt	0.34	-	-	-	0.8	1.18
Pension & Post-Retirement Benefits	12.45	12	11.09	11.94	11.12	10.83
Total Liabilities	28.38	24.84	23.94	20.12	19.49	19.18

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	38.76	38.76	38.76	38.76	38.76	19.38
Retained Earnings	80.85	73.77	63.76	60.52	58.14	70.39
Treasury Stock	-0.21	-0.23	-0.23	-0.23	-0.23	-0.15
Comprehensive Income & Other	1.85	2.32	1.9	5.27	5.91	2.24
Total Common Equity	121.26	114.63	104.2	104.32	102.59	91.86
Minority Interest	0.67	0.73	0.68	0.7	0.92	0.93
Shareholders' Equity	121.93	115.36	104.88	105.02	103.51	92.79
Total Liabilities & Equity	150.3	140.21	128.82	125.15	123	111.98

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.22	-	-	-	1.22	2.03
Net Cash (Debt)	3.82	4.78	15.5	17.19	15.41	11.78
Net Cash Growth	-9.93%	-69.17%	-9.81%	11.53%	30.87%	24.09%
Net Cash Per Share	0.10	0.12	0.40	0.44	0.41	0.30
Filing Date Shares Outstanding	39.84	38.71	38.76	38.71	35.24	38.76
Total Common Shares Outstanding	39.84	38.71	38.76	38.71	35.24	38.76
Working Capital	65.11	57.06	57.21	59.01	60.65	52.44
Book Value Per Share	3.04	2.96	2.69	2.69	2.91	2.37
Tangible Book Value	121.26	114.63	104.2	104.32	102.59	91.86
Tangible Book Value Per Share	3.04	2.96	2.69	2.69	2.91	2.37
Land	-	9.39	9.03	3.95	-	3.58
Buildings	-	13.38	11.71	11.71	-	12.24
Machinery	-	42.62	41.48	41.19	-	40.56
Construction In Progress	-	6.41	7.26	6.04	-	0.44

Data Source: S&P Global Market Intelligence Last updated: Nov 9, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error